BUSINESS
MFs go fishing for value in stock market's most hated pocket
BUSINESS
IT stocks head for worst year since 2008 as growth winter sets in
BUSINESS
RBI Monetary Policy | Just like the Fed, an RBI pivot remains elusive for Dalal Street
BUSINESS
Foreign investors pull out record $18 billion from 8th largest stock market in 2022
BUSINESS
Pivot Powell to China's comeback: 4 global themes that will define investing in 2023
BUSINESS
Why is ICICI Prudential MF doubling down on battered Nykaa?
BUSINESS
Fear index for stock market hits 14-month low as investor confidence builds up
BUSINESS
List of FIIs seeking an out from NSE continues to grow longer
BUSINESS
Buccaneering traders bet Nifty rally has more legs to run on
BUSINESS
Q2 review | IT earnings better than feared but road ahead bumpy
BUSINESS
Diagnostic giant warns cash-burning startups they have got it all wrong
BUSINESS
Worries over UPL's bulging debt fail to enthuse investors despite big-bang private equity placement
BUSINESS
Exclusive | US FDA finds procedural issues at Lupin’s Nagpur injectables plant
BUSINESS
Cipla Q2 preview | Consolidated net profit likely to rise 9% YoY
BUSINESS
How long will US Fed keep raising the interest rate?
BUSINESS
Sun Pharma’s specialty drugs bet is beginning to pay off
BUSINESS
Nykaa’s new CTO aims to embrace crypto, metaverse to boost user engagement
BUSINESS
Preview | UPL to see strong growth in Q2 earnings driven by India operations
BUSINESS
Q2 Preview | Sun Pharma consolidated net may drop 4% on high R&D costs
BUSINESS
Inflation fight likely to trigger Rs 27,000 crore in losses for PSU refiners in Q2
BUSINESS
Dr Reddy’s Q2 preview: Pharma major likely to report sharp drop in net profit on weak US biz
IPO
PharmEasy’s annus horribilis may get worse before it gets better
BUSINESS
Earnings, global factors key to a good show this Samvat
BUSINESS
RIL gains as co to demerge, list Jio Financial Services
